2-Amino-5-bromo-4-methoxypyrimidine, 95.0%, 250mg

Anti-alpha2-6-Sialylated 6-sulfo LacNAc Monoclonal Antibody (KN343)1vial

9-Methylcarbazole>99.0%(GC)25g

(R)-N-(2-(4-Isopropyl-4,5-dihydrooxazol-2-yl)-6-methylphenyl)methanesulfonamide, 98%, 1g

2-Amino-9-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-3H-purine-6,8(7H,9H)-dione, 95.0%, 5g

4-Amino-2,1,3-benzothiadiazole>98.0%(GC)(T)1g

4-Difluoromethoxy-2-methyl-aniline, 95.0%, 25g

Solution étalon ICP de zinc, 100 mL, 1 000 mg/L Zn, HDPE

2-Chloro-4-fluoro-3-methoxybenzoic acid, 98%, 1g

2-(4-Aminophenyl)-2-methylpropanenitrile, 97.0%, 5g

7-Bromobenzothiazole, 95.0%, 250mg

(1R,3R,5R)-2-BOC-2-Azabicyclo[3.1.0]hexane-3-carboxylic acid, 95.0%, 5g

2-(5-Fluoro-2-nitrophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95+%, 25g